[go: up one dir, main page]

NO20016201D0 - Tienopyrimidiner som fosfodiesteraseinhibitorer - Google Patents

Tienopyrimidiner som fosfodiesteraseinhibitorer

Info

Publication number
NO20016201D0
NO20016201D0 NO20016201A NO20016201A NO20016201D0 NO 20016201 D0 NO20016201 D0 NO 20016201D0 NO 20016201 A NO20016201 A NO 20016201A NO 20016201 A NO20016201 A NO 20016201A NO 20016201 D0 NO20016201 D0 NO 20016201D0
Authority
NO
Norway
Prior art keywords
tienopyrimidines
phosphodiesterase inhibitors
phosphodiesterase
inhibitors
Prior art date
Application number
NO20016201A
Other languages
English (en)
Other versions
NO20016201L (no
Inventor
Rochus Jonas
Pierre Schelling
Franz-Werner Kluxen
Maria Christadler
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20016201L publication Critical patent/NO20016201L/no
Publication of NO20016201D0 publication Critical patent/NO20016201D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20016201A 1999-06-19 2001-12-18 Tienopyrimidiner som fosfodiesteraseinhibitorer NO20016201D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19928146A DE19928146A1 (de) 1999-06-19 1999-06-19 Thienopyrimidine
PCT/EP2000/005278 WO2000078767A1 (de) 1999-06-19 2000-06-07 Thienopyrimidine als phosphodiesterase hemmer

Publications (2)

Publication Number Publication Date
NO20016201L NO20016201L (no) 2001-12-18
NO20016201D0 true NO20016201D0 (no) 2001-12-18

Family

ID=7911858

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016201A NO20016201D0 (no) 1999-06-19 2001-12-18 Tienopyrimidiner som fosfodiesteraseinhibitorer

Country Status (24)

Country Link
US (1) US6787548B1 (no)
EP (1) EP1189907B1 (no)
JP (1) JP2003502429A (no)
KR (1) KR20020010719A (no)
CN (1) CN1144806C (no)
AR (1) AR024380A1 (no)
AT (1) ATE285412T1 (no)
AU (1) AU767273B2 (no)
BR (1) BR0011778A (no)
CA (1) CA2375278A1 (no)
CZ (1) CZ293901B6 (no)
DE (2) DE19928146A1 (no)
ES (1) ES2234613T3 (no)
HK (1) HK1047434B (no)
HU (1) HUP0201730A3 (no)
MX (1) MXPA01013228A (no)
NO (1) NO20016201D0 (no)
PL (1) PL351822A1 (no)
PT (1) PT1189907E (no)
RU (1) RU2238274C2 (no)
SK (1) SK18222001A3 (no)
UA (1) UA72256C2 (no)
WO (1) WO2000078767A1 (no)
ZA (1) ZA200200440B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19944604A1 (de) * 1999-09-17 2001-03-22 Merck Patent Gmbh Aminderivate
DE10001021A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische Zubereitung
DE10010612A1 (de) * 2000-03-03 2001-09-27 Merck Patent Gmbh Verwendung von PDE V-Inhibitoren
DE10017947A1 (de) * 2000-04-11 2001-10-25 Merck Patent Gmbh Verfahren zur Herstellung benzo-annelierter Heterocyclen
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10107261B4 (de) * 2001-02-16 2005-03-10 Merck Patent Gmbh Pharmazeutische Zusammensetzung
JPWO2003035653A1 (ja) * 2001-10-26 2005-02-10 日本曹達株式会社 ピリドチエノピリミジン化合物およびその塩
RU2409581C2 (ru) * 2004-12-13 2011-01-20 Зольвай Фармасьютиклз Гмбх НОВЫЕ ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ТИОФЕНПИРИМИДИНОНА В КАЧЕСТВЕ ИНГИБИТОРОВ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
JP2009513672A (ja) 2005-10-31 2009-04-02 ブレインセルス，インコーポレイティド 神経発生のｇａｂａ受容体媒介調節
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19644228A1 (de) 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19819023A1 (de) 1998-04-29 1999-11-04 Merck Patent Gmbh Thienopyrimidine

Also Published As

Publication number Publication date
ZA200200440B (en) 2003-06-25
BR0011778A (pt) 2002-04-23
HUP0201730A3 (en) 2004-12-28
CZ20014422A3 (cs) 2002-03-13
HK1047434A1 (en) 2003-02-21
ES2234613T3 (es) 2005-07-01
AR024380A1 (es) 2002-10-02
KR20020010719A (ko) 2002-02-04
CZ293901B6 (cs) 2004-08-18
SK18222001A3 (sk) 2002-06-04
EP1189907A1 (de) 2002-03-27
ATE285412T1 (de) 2005-01-15
WO2000078767A1 (de) 2000-12-28
CN1144806C (zh) 2004-04-07
DE19928146A1 (de) 2000-12-21
RU2238274C2 (ru) 2004-10-20
AU767273B2 (en) 2003-11-06
MXPA01013228A (es) 2002-07-02
US6787548B1 (en) 2004-09-07
EP1189907B1 (de) 2004-12-22
NO20016201L (no) 2001-12-18
PT1189907E (pt) 2005-05-31
JP2003502429A (ja) 2003-01-21
HUP0201730A2 (en) 2002-09-28
HK1047434B (zh) 2005-01-28
PL351822A1 (en) 2003-06-16
UA72256C2 (uk) 2005-02-15
CA2375278A1 (en) 2000-12-28
AU5220400A (en) 2001-01-09
DE50009042D1 (en) 2005-01-27
CN1355805A (zh) 2002-06-26

Similar Documents

Publication Publication Date Title
NO20021239L (no) Pteridinoner som kinase-inhibitorer
NO20023828L (no) Pyrimidin-4-on derivater som LDL-PLA2 inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20015065D0 (no) Pyrazolobenzodiazepiner som CDK2-inhibitorer
DK1289985T3 (da) Beta-carbolinderivater anvendelige som phosphodiesteraseinhibitorer
DK2253620T3 (da) Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
PT1181017E (pt) Inibidores de metaloproteases
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
NO20031006L (no) Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon
NO20014642L (no) Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
PT1224195E (pt) C-aril-glicosidos inibidores de tgls2
ATE318603T1 (de) Pyrrolotriazin kinasehemmer
ATE433451T1 (de) Xanthin-phosphodiesteras-v-inhibitoren
DK1140840T3 (da) omega-carboxyaryl-substituerede diphenylurinstoffer som raf-kinase-inhibitorer
DK1049695T3 (da) 2-Phenyl-substituerede imidazotriazinoner som phosphodiesterase-inhibitorer
PT1194404E (pt) Inibidores de aspartil-protease
NO20024997D0 (no) 2-guanidino-4-arylkinazoliner som NHE-3-inhibitorer
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
DK1226143T3 (da) Imidazopyridinderivater som phosphodiesterase VII-inhibitorer
DK1272488T3 (da) Tri-aryl-substitueret ethan-PDE4-inhibitorer
DK1228073T3 (da) Imidazolforbindelser som phosphodiesterase VII-inhibitorer
NO20014243D0 (no) Dihetero-substituerte metalloprotease inhibitorer
NO20021959D0 (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO20022123D0 (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
DK1222193T3 (da) Imidazolderivater som phosphodiesterase VII-inhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application